During this webinar you’ll learn about the recently launched Xevo G3 QTof system and discover how its solving problems that matter.
Professor Clare Mills discusses the use of an LC/MS metabolomics approach to profile serum from COVID-19 inpatients. Here they describe how to identify and characterize prognostic biomarkers to support the development of mass spectrometry rapid clinical screening tools.
Tune in to hear more about how the team are planning to characterize immune disfunction as a consequence of SARS-CoV-2 infection.
Key learning objectives
Who should attend?
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.